Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-09 Sale | 2022-02-11 6:10 pm | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 397 | $36.3 | $14,411 | 65,848 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:09 pm | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 221 | $36.3 | $8,022 | 96,961 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:09 pm | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 669 | $36.3 | $24,285 | 86,579 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:08 pm | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer | 669 | $36.3 | $24,285 | 109,188 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 6:07 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 2,971 | $36.3 | $107,847 | 334,970 (Direct) | View |
| 2021-08-30 Sale | 2021-08-31 5:26 pm | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 10,000 | $80 | $800,000 | 156,974 (Direct) | View |
| 2021-07-14 Sale | 2021-07-15 5:53 pm | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 1,869 | $74.9 | $139,988 | 21,767 (Direct) | View |
| 2021-06-21 Purchase | 2021-06-21 9:14 pm | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 2,000 | $81.34 | $162,680 | 2,000 (Direct) | View |
| 2021-06-15 Sale | 2021-06-16 5:16 pm | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 15,000 | $77.03 | $1,155,433 | 166,974 (Direct) | View |
| 2021-03-22 Sale | 2021-03-24 9:54 pm | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 28,435 | $100.65 | $2,862,082 | 32,443 (Direct) | View |
| 2021-03-08 Sale | 2021-03-09 7:26 pm | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 20,000 | $109.8 | $2,195,939 | 181,974 (Direct) | View |
| 2021-03-04 Sale | 2021-03-05 8:56 pm | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $105.04 | $3,734,075 | 118,295 (Direct) | View |
| 2021-02-09 Sale | 2021-02-11 8:28 pm | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 60,000 | $137.48 | $8,249,038 | 681,213 (Direct) | View |
| 2021-02-01 Sale | 2021-02-02 9:50 pm | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 25,000 | $125.89 | $3,147,363 | 399,998 (Direct) | View |
| 2021-02-01 Sale | 2021-02-02 9:47 pm | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 30,000 | $126.73 | $3,801,918 | 581,796 (Direct) | View |
| 2021-01-07 Sale | 2021-01-08 9:08 pm | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 31,238 | $122.26 | $3,819,090 | 57,770 (Direct) | View |
| 2021-01-04 Sale | 2021-01-05 9:03 pm | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 10,300 | $120.43 | $1,240,406 | 339,921 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-11 Option Award | 2022-04-12 6:46 pm | N/A 2032-04-10 | Turning Point Therapeutics Inc. | TPTX | Sun Brian VP | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:11 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO CFO | 74,883 | $0 | 88,483 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:10 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 62,400 | $0 | 65,848 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:09 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 74,883 | $0 | 96,961 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:09 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 74,883 | $0 | 86,579 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:08 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP & Chief Medical Officer | 102,350 | $0 | 109,188 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 6:07 pm | N/A 2032-02-08 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 287,040 | $0 | 334,970 (Direct) | View |
| 2021-08-30 Exercise | 2021-08-31 5:26 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 10,000 | $0 | 156,974 (Direct) | View |
| 2021-08-30 Exercise | 2021-08-31 5:26 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 10,000 | $17 | 156,974 (Direct) | View |
| 2021-07-26 Option Award | 2021-07-27 6:22 pm | N/A 2031-07-25 | Turning Point Therapeutics Inc. | TPTX | TOMBESI PAOLO CFO | 74,800 | $0 | 74,800 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-16 5:16 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 15,000 | $0 | 166,974 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-16 5:16 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 15,000 | $17 | 166,974 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:44 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | George Simeon Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:41 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Machado Patrick Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:39 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Gallagher Carol Giltner Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:37 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Nicholson Garry A Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:34 pm | N/A 2031-06-01 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 209 | $0 | 209 (Direct) | View |
| 2021-05-24 Option Award | 2021-05-26 4:50 pm | N/A 2031-05-23 | Turning Point Therapeutics Inc. | TPTX | Alles Mark J Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2021-05-06 Exercise | 2021-05-07 4:37 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 5,882 | $0 | 181,974 (Direct) | View |
| 2021-05-06 Exercise | 2021-05-07 4:37 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 5,882 | $17 | 181,974 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-01 9:01 pm | N/A 2031-03-30 | Turning Point Therapeutics Inc. | TPTX | Bodem Barbara W. Director | 14,995 | $0 | 14,995 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A 2027-08-08 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 28,435 | $0 | 32,443 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 11,904 | $2.19 | 32,443 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 4,545 | $5.12 | 32,443 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,298 | $3.2 | 32,443 (Direct) | View |
| 2021-03-22 Exercise | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 10,688 | $7.43 | 32,443 (Direct) | View |
| 2021-03-22 Option Award | 2021-03-24 9:54 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,625 | $0 | 32,443 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-09 7:26 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 20,000 | $0 | 181,974 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-09 7:26 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 20,000 | $17 | 181,974 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 8:56 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $51.28 | 118,295 (Direct) | View |
| 2021-03-04 Exercise | 2021-03-05 8:56 pm | N/A 2030-03-01 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 35,550 | $0 | 118,295 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A 2028-06-05 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 60,000 | $0 | 681,213 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 8:28 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 60,000 | $3.2 | 681,213 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 6:03 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 35,658 | $0 | 35,942 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 6:01 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 35,658 | $0 | 35,658 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:59 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer | 11,869 | $0 | 33,369 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:58 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 25,392 | $0 | 28,096 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:55 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Reich Siegfried EVP & Chief Scientific Officer | 21,148 | $0 | 21,148 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:53 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 8,158 | $0 | 9,166 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:52 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Countouriotis Athena CEO | 124,392 | $0 | 151,970 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:50 pm | N/A 2029-04-14 | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 25,000 | $0 | 399,998 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:50 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | North Annette VP | 25,000 | $17 | 399,998 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A 2029-08-25 | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 30,000 | $0 | 581,796 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Larson Yi CFO | 30,000 | $54.03 | 581,796 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A 2027-08-08 | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 28,438 | $0 | 57,770 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 11,905 | $2.19 | 57,770 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 4,545 | $5.12 | 57,770 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 1,299 | $3.2 | 57,770 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-08 9:08 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Baker Brian Lee VP | 10,689 | $7.43 | 57,770 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-05 9:03 pm | N/A 2029-12-01 | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 10,000 | $0 | 339,921 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-05 9:03 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Hirmand Mohammad EVP and Chief Medical Officer | 10,000 | $54.73 | 339,921 (Direct) | View |